Delivery Order SPE2DB22D3004-SPE2DB25FRF96
Award Date 6/30/25
Potential Completion Date 7/22/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (30-count units) under a firm fixed-price contract valued at $1,165.05. The award was made on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.48 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (100-count units) on November 6, 2025, with an ultimate completion date of December 1, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,358.25 to supply Envarsus XR 1 mg tablets (100-count) with a firm fixed price and a completion date of December 8, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,804.13 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100 count) on November 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100-count units) under a competitive, non-set-aside procurement. The contract has a ceiling value of $1,718.48 with a firm fixed-price structure and an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) valued at $3,608.26. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,288.86. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,148.10 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Envarsus XR 1 mg tablets (100-count). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with federal medical procurement. The work will be performed at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,263.75 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product. The award, announced on November 3, 2025, with an ultimate completion date of November 25, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order through its Corporate Office division, leveraging its position as a...
- The Defense Logistics Agency has awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count packaging). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by October 21, 2025. The contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania, where AmerisourceBergen maintains operations as a primary pharmaceutical...